Salveen Richter
Stock Analyst at Goldman Sachs
(3.43)
# 952
Out of 5,090 analysts
204
Total ratings
42.11%
Success rate
6.38%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $27.73 | -9.84% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $9.90 | +11.11% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $21.33 | +78.15% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $25.45 | -37.13% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $81.68 | -20.42% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $23.63 | -23.83% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $19.76 | +31.58% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $458.12 | +23.55% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $10.70 | +255.14% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $22.26 | -14.65% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $27.44 | -38.05% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.81 | +69.65% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $56.88 | -17.37% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $53.40 | +94.76% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $18.31 | +123.92% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $14.75 | -32.20% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $718.36 | +11.92% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $181.30 | +8.66% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $7.68 | +134.38% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $121.22 | -20.81% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $27.70 | +84.12% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $19.96 | +100.40% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $9.61 | +24.87% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $102.52 | -31.72% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $36.38 | +108.91% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $329.89 | +6.10% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $455.48 | +22.73% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $29.91 | -83.28% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.43 | +2,067.83% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $306.74 | -26.65% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.74 | +488.24% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $25.47 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.02 | +497.61% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.71 | +91.08% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $5.05 | -40.59% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $5.13 | +16.96% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $72.21 | -40.45% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.74 | -57.81% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $14.33 | +597.84% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $9.21 | +6,414.66% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $110.33 | -54.68% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $61.44 | -26.76% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $27.73
Upside: -9.84%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $9.90
Upside: +11.11%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $21.33
Upside: +78.15%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $25.45
Upside: -37.13%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $81.68
Upside: -20.42%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $23.63
Upside: -23.83%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $19.76
Upside: +31.58%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $458.12
Upside: +23.55%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $10.70
Upside: +255.14%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $22.26
Upside: -14.65%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $27.44
Upside: -38.05%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $21.81
Upside: +69.65%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $56.88
Upside: -17.37%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $53.40
Upside: +94.76%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $18.31
Upside: +123.92%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $14.75
Upside: -32.20%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $718.36
Upside: +11.92%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $181.30
Upside: +8.66%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.68
Upside: +134.38%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $121.22
Upside: -20.81%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $27.70
Upside: +84.12%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $19.96
Upside: +100.40%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.61
Upside: +24.87%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $102.52
Upside: -31.72%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $36.38
Upside: +108.91%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $329.89
Upside: +6.10%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $455.48
Upside: +22.73%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $29.91
Upside: -83.28%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.43
Upside: +2,067.83%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $306.74
Upside: -26.65%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.74
Upside: +488.24%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $25.47
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.02
Upside: +497.61%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.71
Upside: +91.08%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $5.05
Upside: -40.59%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $5.13
Upside: +16.96%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $72.21
Upside: -40.45%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.74
Upside: -57.81%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $14.33
Upside: +597.84%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $9.21
Upside: +6,414.66%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $110.33
Upside: -54.68%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $61.44
Upside: -26.76%